FDA approves Pharming’s Joenja for children
FDA approves Pharming’s Joenja for children The Pharma Letter
Regulatory Approvals
FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients
FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients Oncology Nursing News
Scholar Rock wins FDA approval for ISEMBYLD, the first muscle-targeted treatment for spinal muscular atrophy
Scholar Rock wins FDA approval for ISEMBYLD, the first muscle-targeted treatment for spinal muscular atrophy Dealroom
FDA Approves Apitegromab for Spinal Muscular Atrophy
FDA Approves Apitegromab for Spinal Muscular Atrophy NeurologyLive
Scholar Rock wins FDA approval for first drug to target SMA muscle loss
Scholar Rock wins FDA approval for first drug to target SMA muscle loss STAT